Hospital for Special Surgery, New York
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Hospital for Special Surgery, New York sits in the top decile of US sponsors by registered trial count (#155 of 15,742 sponsors by registered trial count).
Hospital for Special Surgery, New York: 194 sponsored US clinical trials, 35 recruiting.
Hospital for Special Surgery, New York sponsors 194 registered US clinical trials on ClinicalTrials.gov, 35 of them currently recruiting, and 123 completed. 58 of these trials are in Phase 3-4 (later-stage) and 19 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Opioid Use, with 7 trials.
Top-decile sponsor footprint
Hospital for Special Surgery, New York ranks in the top decile of sponsors by registered trial count (#155 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
123 of 145 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
194 total, page 1 of 4
Opioid Dispenser for Microdiscectomy/Laminectomy
NCT06358040
Safety and Efficacy of ONT01 in Lupus
NCT07107659
Impact of Bone-Marrow Aspirate Injections in Knee Arthroscopy
NCT06893302
Does Joint Immobilization Following Revision Total Knee Arthroplasty Improve Range of Motion Following Surgery?
NCT07552415
Comparing Original Patient Educational Materials vs. AI-Simplified Materials to Improve Patient Comprehension and Health Literacy
NCT07505719
Suzetrigine in Total Hip Arthroplasty
NCT07226700
Anterior Femoral and Adductor Canal Nerve Blocks in Peds Knees
NCT06590402
Robotic Knee Orthosis-assisted Walking in CP
NCT06887764
Post-Operative Thoracolumosacral Orthosis for PJK
NCT06491030
Early Versus Delayed Bathing of Orthopaedic Surgical Wounds
NCT06014411
Concentrated Bone Marrow Aspirate in Revision ACL Reconstruction
NCT06311513
Cervical Radiculopathy Imaging Using MRN With Electrodiagnostic Correlation
NCT06971575
Lumoptik BRIGHTPOINT Reflectometer Device for Lumbar Epidural Placement
NCT06020508
Enhanced Recovery After Major Surgery and Chronic Pain for Total Knee Arthroplasty
NCT05981105
ESP Block in MIS Lumbar Spine Surgery
NCT05856539
PRP for Glenohumeral Osteoarthritis
NCT05675527
Infrared Images for Spinal Cord Stimulation in Complex Regional Pain Syndrome Patients
NCT05777889
Return to Golf After Orthopaedic Surgery
NCT05675618
JUPITER 4.0 - Risk Factors for Failure of Isolated Medial Patellofemoral Ligament Reconstruction
NCT06883396
Preoperative Oral Hydration in the Ambulatory Arthroplasty Population
NCT05520593
Analysis of T and B Cell Repertoire Changes in Response to Orencia® (Abatacept) in Rheumatoid Arthritis
NCT05782335
PRP in ACLR to Prevent PTOA
NCT05412381
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression
NCT05058287
Categorized PT for Non-arthritic Hip and Groin Pain
NCT04720846
Effects of Bisphosphonates on OI-Related Hearing Loss
NCT04152551
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
NCT03841058
Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis
NCT03844061
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
NCT03747146
Tranexamic Acid in Adult Spinal Deformity Surgery
NCT03553186
Using MRI To Detect Soft Tissue Reactions And Implant Integration As Related To Implant Modularity
NCT02255331
Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis
NCT03704766
Undifferentiated Connective Tissue Disease Registry
NCT02234388
Hospital for Special Surgery Shoulder Arthroplasty Cohort
NCT00527839
Scleroderma Registry & Repository at the Hospital for Special Surgery
NCT01656447
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
NCT00198068
Forward Looking InfraRed Imaging and Severity Score in Complex Regional Pain Syndrome
NCT05852210
Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone
NCT04467983
Doxycycline for Elbow Tendinopathy
NCT04686799
Shockwave Therapy for Plantar Fasciitis RCT
NCT04332471
Barriers to Efficient PACU Discharge at a Major Academic Orthopaedic Ambulatory Surgery Center
NCT04356612
Intralipid® 20% for Reversal of Local Anesthetics
NCT03968822
Intravenous (IV) Hydrocortisone for TKA (Total Knee Arthroplasty)
NCT04082533
Stromal Vascular Fraction Cell Therapy to Improve the Repair of Rotator Cuff Tears
NCT03332238
Use of Dalfampridine in Primary Lateral Sclerosis
NCT02868567
Increasing Long-Term Physical Activity After Lumbar Spine Surgery
NCT02611427
Comparing Patients' and Surgeons' Expectations of Lumbar Spine Surgery
NCT02257554
Hospital for Special Surgery Knee Arthroplasty Cohort
NCT00454467
Hospital for Special Surgery Hip Arthroplasty Cohort
NCT00454506
Fiber Smoothie Supplement
NCT06896240
Gastric Ultrasound Assessment for Patients Taking Cannabis
NCT06567873
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 14 |
| Phase 3 | 8 |
| Phase 4 | 50 |
Therapeutic Areas
Where Hospital for Special Surgery, New York enrollment is open (later-stage tilt)
35 recruiting of 194 indexed (18% open); 123 completed (63%).
Phase mix: 58 late (III/IV) vs 19 early (I/II) (later-stage heavy).
Top condition: Opioid Use (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Hospital for Special Surgery, New York: open-pipeline peers nationwide
Peers matched on 194 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Hospital for Special Surgery, New York sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 194 trials (± recruiting share)
- Genzyme, a Sanofi Company · 196 trials · 2% recruiting
- Vertex Pharmaceuticals Incorporated · 191 trials · 10% recruiting
- Vanderbilt-Ingram Cancer Center · 189 trials · 15% recruiting
- Nationwide Children's Hospital · 188 trials · 15% recruiting
Sponsors near 18% open enrollment (± trial volume)
- George Washington University · 18% recruiting · 133 trials
- West Virginia University · 18% recruiting · 122 trials
- University of California, Berkeley · 18% recruiting · 72 trials
- Children's Hospital of Philadelphia · 18% recruiting · 431 trials
Related
What to do with this Hospital for Special Surgery, New York page
194 registered trials is a research-attention snapshot, not an endorsement of Hospital for Special Surgery, New York or any single study.
- 35 of Hospital for Special Surgery, New York's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Opioid Use is the condition Hospital for Special Surgery, New York studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Opioid Use trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Hospital for Special Surgery, New York pipeline card: 194 registered trials from official public datasets.Report a data error.